Eisai Temporarily Withdraws New Drug Application for Anticancer Agent Halaven in China
Eisai Co., Ltd. announced today that, in alignment with Chinese regulations, it has temporarily withdrawn...
Sandoz receives approval in Europe for Rixathon® to treat blood cancers and immunological diseases
Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, announced today that...
Numerate and Takeda Enter Agreement to Generate Novel Clinical Candidates Using AI-Driven Drug Discovery
Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to...
Eisai Enters Into Joint Research Agreement With The Broad Institute To Develop An Antimalarial...
Eisai Co Ltd announced that it has entered into a new joint research agreement with...
OBI Pharma to develop OBI-3424 (previously TH-3424) as a potential treatment of cancers expressing...
OBI Pharma, Inc., a Taiwan biopharma company announced an agreement with Threshold Pharmaceuticals, Inc. to...
Organs-On-Chips To Revolutionize The Drug Development Industry
The market for organs-on-chips (OOCs), the cell culture chips that imitate the activities, mechanisms and...
Beactica announces glioblastoma research collaboration with Uppsala University and the DDD Platform at SciLifeLab
Beactica AB, the Swedish drug discovery company announced a new research collaboration with Uppsala University...
InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery
InMed Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the research and development of novel,...
Aptar Pharma Partners with Kali Care to Develop Real-Time Medication Management Technology
Aptar Pharma and Kali Care have announced that they entered into a partnership in order...
Top Loading Autoclaves for Labs on a Budget
The QCS EV 100 litre top loading autoclave is among the most space-efficient sterilisers available...
